Reuters: Regulatory News: UPDATE 1-FDA issues recall on Thoratec HeartMate II pump

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-FDA issues recall on Thoratec HeartMate II pump Apr 4th 2012, 19:06 Wed Apr 4, 2012 3:06pm EDT * Thoratec changes label to prevent serious side effects * Announcement made public by FDA on Wednesday * Thoratec shares fall 5.7 percent April 4 (Reuters) - The Food and Drug Administration issued a recall Wednesday of Thoratec Corp's HeartMate II pump after it was found that a key part of the surgical procedure was omitted from the instructions, which could lead to serious side effects or even death. Analysts said, however, that the recall does mean the product will have to be removed from the shelves and Thoratec does not have to halt marketing the product. The announcement was posted by the FDA on its website, and Thoratec's shares fell 5.7 percent, to $32.39, in afternoon trading. The FDA said described the action as a Class I recall, the most serious type, and said clinicians have been instructed to follow the revised instructions for use, which "clarify the recommended procedure for securing the bend relief to the outflow graft." If the two parts of the device are not secured correctly, the FDA said, the product may cause serious health consequences, including death. A new caution statement regarding the connection is included in the new label. Thoratec was not immediately available for comment. Link this Share this Digg this Email Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions